Food Challenge With Barley Starch as Active Comparator
NCT03352856 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2019-03-05
Summary
Aim of the present study is to verify in a double-blind placebo controlled food challenge (DBPCFC) test that highly purified barley starch ingredient do not cause allergic reaction in subjects most potential to get allergic reaction due to ingredient. Hypothesis is that none of the cereal (mostly primarily wheat) allergic subject recruited to the study will obtain allergic reaction neither to placebo nor to the test ingredient. Scoring of symptoms during the challenges will be based on PRACTALL.
Conditions
- Allergy;Food
- Allergy Wheat
Interventions
- OTHER
-
Barley starch
Highly purified barley starch
- OTHER
-
Maize starch
Maize starch
Sponsors & Collaborators
-
FinnMedi Oy
collaborator INDUSTRY -
Oy Medfiles Ltd
collaborator INDUSTRY -
Lyckeby Starch AB
lead INDUSTRY
Principal Investigators
-
Marita Paassilta, MD, Docent · Tampere University Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- QUADRUPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 1 Year
- Max Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-10-13
- Primary Completion
- 2020-12-31
- Completion
- 2021-03-31
Countries
- Finland
Study Locations
More Related Trials
-
Endophenotyping for Plant-based Food Allergy Diagnosis, Tolerance Biomarkers, and Mechanisms in Microneedle Immunotherapy
NCT06997432 ·Status: NOT_YET_RECRUITING
-
Oral Desensitization to Wheat in School Aged Children
NCT01755884 ·Status: COMPLETED ·Phase: NA
-
Food Challenge at Home or in Medical Practice - the FoodCHOMP Study
NCT06916819 ·Status: RECRUITING ·Phase: NA
-
Safety and Tolerability Study of Larazotide Acetate in Celiac Disease Subjects
NCT00362856 ·Status: COMPLETED ·Phase: PHASE2
-
Dietary Intervention in Food Allergy
NCT06386081 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Celiac Disease
NCT02637141 ·Status: COMPLETED ·Phase: PHASE2
-
Pectin Intervention Study and Long-term Follow-up in Lipid Transfer Proteins Allergic Patients
NCT06558526 ·Status: RECRUITING ·Phase: NA
-
Safety and Efficacy of Varying Methods of ALV003 Administration for the Treatment of Celiac Disease
NCT01255696 ·Status: COMPLETED ·Phase: PHASE2
-
Mixed Tree Nut Food Challenges
NCT02070263 ·Status: UNKNOWN
-
Prevalence of Food Allergies to Proteins From Different Legumes
NCT01728168 ·Status: COMPLETED
-
Lymphocytic Enteritis and Suspected Coeliac Disease: Gluten vs Placebo
NCT02472704 ·Status: COMPLETED ·Phase: NA
-
A Study of TAK-062 in Treatment of Active Celiac Disease in Participants Attempting a Gluten-Free Diet
NCT05353985 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Ancient Grains-based Diet in a Closed Community
NCT03020511 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Potential Allergenicity of New Soybean Varieties
NCT01950559 ·Status: TERMINATED
-
Wheat Bread Study: Comparison of the Tolerance of Different Wheat Breads
NCT06152445 ·Status: RECRUITING ·Phase: NA
-
Serum Markers in Gluten Challenge
NCT00931892 ·Status: COMPLETED ·Phase: NA
-
Tolerability of an Ancient Grain in Patients With Non-Celiac Wheat Sensitivity
NCT06191432 ·Status: RECRUITING ·Phase: NA
-
Bioelectrical Impedance Analysis of Not-celiac Wheat Sensitivity Patients
NCT01762566 ·Status: COMPLETED ·Phase: NA
-
In Vivo Effects of the Gluten Friendly Bread in Coeliac Disease
NCT03168490 ·Status: TERMINATED ·Phase: NA
-
Changes in Intestinal Permeability 4 Hours After Gluten Challenge
NCT03288831 ·Status: COMPLETED ·Phase: NA
-
Non-Celiac Wheat Sensitivity: Permanent or Transient Condition?
NCT02823522 ·Status: COMPLETED
-
Efficacy of Local Food Extracts at Different Storage Times
NCT02774629 ·Status: UNKNOWN
-
Prevalence of Non Celiac Gluten Sensitivity Among Patients Spontaneously Adherent to Gluten Free Diet
NCT01827566 ·Status: UNKNOWN ·Phase: NA
-
Safety and Efficacy of ALV003 for the Treatment of Celiac Disease
NCT00959114 ·Status: COMPLETED ·Phase: PHASE2
-
Randomized, Double-Blind, Placebo-Controlled Study of Larazotide Acetate in Subjects With Active Celiac Disease
NCT00620451 ·Status: COMPLETED ·Phase: PHASE2